TNFRSF17 and plasma cell myeloma: The immunofluorescence liquid biopsy assay reported here for the identification and morphological delineation of circulating tumor cells in B-lymphoid malignancies has potential utility in the early detection of myeloma and monitoring of therapy response for patients undergoing anti-BCMA treatment.